Bicycle Therapeutics (BCYC) Research & Development (2018 - 2025)
Historic Research & Development for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $58.4 million.
- Bicycle Therapeutics' Research & Development rose 2105.25% to $58.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.3 million, marking a year-over-year increase of 4193.7%. This contributed to the annual value of $173.0 million for FY2024, which is 1052.42% up from last year.
- Per Bicycle Therapeutics' latest filing, its Research & Development stood at $58.4 million for Q3 2025, which was up 2105.25% from $71.0 million recorded in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' Research & Development peaked at $71.0 million during Q2 2025, and registered a low of $9.7 million during Q1 2021.
- Its 5-year average for Research & Development is $33.9 million, with a median of $34.9 million in 2024.
- As far as peak fluctuations go, Bicycle Therapeutics' Research & Development surged by 12550.41% in 2023, and later soared by 85.35% in 2024.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Research & Development stood at $13.0 million in 2021, then soared by 90.79% to $24.7 million in 2022, then skyrocketed by 80.82% to $44.7 million in 2023, then increased by 11.37% to $49.8 million in 2024, then increased by 17.37% to $58.4 million in 2025.
- Its last three reported values are $58.4 million in Q3 2025, $71.0 million for Q2 2025, and $59.1 million during Q1 2025.